For on-demand treatment of acute hereditary angioedema (HAE) attacks

Get back fast* from HAE attacks

  • 15 minutes for laryngeal attacks
  • 48 minutes for abdominal/facial attacks
*Median time to complete resolution of HAE symptoms was 4.9 hours in a phase 3 clinical trial and 8.4 hours in an open-label extension.
Median time to onset of relief.

BERINERT is the only C1 esterase inhibitor (C1-INH) approved for on-demand treatment of acute abdominal, facial, or laryngeal attacks of hereditary angioedema (HAE) in adults and pediatrics.

HAE diagnostic tool: Differentiate with 8

8 simple questions can help differentiate HAE from other angioedema.

Download PDF (Differentiate with 8)
Download PDF (Therapy journal)

Patient resource: Treatment plan and therapy journal

Your patients can use this resource to plan, prepare, and personalize their approach to managing HAE. They can also record a range of important details about their attacks, symptoms, and treatment to share with you during visits.

Download PDF
You are now leaving the current website.

Do you want to continue?


No Yes